home / stock / abeo / abeo quote
Last: | $5 |
---|---|
Change Percent: | 0.0% |
Open: | $5.11 |
Close: | $5 |
High: | $5.33 |
Low: | $4.97 |
Volume: | 170,107 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5 | $5.11 | $5 | $5.33 | $4.97 | 170,107 | 07-22-2024 |
$5.11 | $5.06 | $5.11 | $5.26 | $5.03 | 249,140 | 07-19-2024 |
$5.04 | $5.41 | $5.04 | $5.54 | $4.81 | 1,096,190 | 07-18-2024 |
$5.42 | $5.28 | $5.42 | $5.52 | $5.17 | 543,544 | 07-17-2024 |
$5.34 | $5.47 | $5.34 | $5.56 | $5.28 | 495,532 | 07-16-2024 |
$5.39 | $5.58 | $5.39 | $5.7 | $5.3 | 475,248 | 07-15-2024 |
$5.51 | $5.2 | $5.51 | $5.6 | $5.2 | 631,060 | 07-12-2024 |
$5.19 | $5.13 | $5.19 | $5.305 | $5.06 | 515,646 | 07-11-2024 |
$4.99 | $5.01 | $4.99 | $5.18 | $4.9 | 310,319 | 07-10-2024 |
$5 | $4.79 | $5 | $5.1942 | $4.79 | 639,582 | 07-09-2024 |
$4.8 | $4.54 | $4.8 | $4.88 | $4.5387 | 458,280 | 07-08-2024 |
$4.54 | $4.4 | $4.54 | $4.55 | $4.29 | 367,944 | 07-05-2024 |
$4.35 | $4.25 | $4.35 | $4.39 | $4.16 | 199,723 | 07-04-2024 |
$4.35 | $4.25 | $4.35 | $4.39 | $4.16 | 199,723 | 07-03-2024 |
$4.12 | $4.15 | $4.12 | $4.22 | $4.11 | 160,043 | 07-02-2024 |
$4.2 | $4.22 | $4.2 | $4.325 | $4.18 | 120,193 | 07-01-2024 |
$4.24 | $4.17 | $4.24 | $4.24 | $4.07 | 243,888 | 06-28-2024 |
$4.19 | $4.06 | $4.19 | $4.255 | $4.04 | 177,635 | 06-27-2024 |
$4.09 | $4.2 | $4.09 | $4.2 | $4.06 | 221,280 | 06-26-2024 |
$4.22 | $4.3 | $4.22 | $4.3104 | $4.1 | 382,695 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Abeona Therapeutics Inc. Company Name:
ABEO Stock Symbol:
NASDAQ Market:
Abeona Therapeutics Inc. Website:
CLEVELAND and LONDON, July 11, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a cell and gene therapy company with proprietary adeno-associated virus (AAV)-based capsids, and Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, today announced ...
CLEVELAND, July 08, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Abeona’s Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., and Chief Commercial Officer, Madhav Vasanthavada, Ph.D., M.B.A., will participate in a virtual fireside chat at the Sti...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ABEO on July 3, 2024 06:07AM ET. ABEO was trading at $4.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...